Hugel Accelerates Entry into Indonesian Toxin Market with 'Letybo' Training Program

Hugel Co., Ltd., a global total medical aesthetics company, is accelerating its efforts to penetrate the Indonesian market.

On April 26, Hugel conducted a 'Letybo' training program for about 200 Indonesian healthcare professionals and medical stakeholders. The event was part of the annual 'Parvus Summit,' organized by the local distributor Parvus.

Hugel conducted the 'Letybo' training program in Indonesia. Hugel

원본보기 아이콘

As a Korean healthcare professional (HCP), Youngjin Park, director of Songdo Obliv Clinic, participated as the keynote speaker and highlighted the advantages of Letybo's narrow diffusion profile. Director Park emphasized, "Letybo allows for precise procedures that deliver effects only to the targeted areas, thereby reducing the potential for side effects."

Hugel, which entered the Indonesian market in September 2024, expects that this event will help increase local healthcare professionals' understanding and usage of Letybo, while also strengthening brand loyalty.

Jang Duhyun, CEO of Hugel, stated, "Indonesia is not only a populous nation but is also experiencing robust economic growth, which is rapidly expanding the medical aesthetics market. Through ongoing academic exchanges with local healthcare professionals, we will continue to enhance Letybo's competitiveness and raise its brand awareness."

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.